𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factors associated with exposure to hepatitis B virus in injection drug users

✍ Scribed by Markus Backmund; Kirsten Meyer; Christian Schuetz; Jens Reimer

Book ID
116411557
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
127 KB
Volume
84
Category
Article
ISSN
0376-8716

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of hepatitis B virus and risk
Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users
✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

Factors associated with fulminant liver
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B
✍ Richard S. Garfein; William A. Bower; Cherry M. Loney; Yvan J. F. Hutin; Guo-Lia πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 922 KB

Death related to acute hepatitis B occurs in approximately 1% of patients. We investigated an outbreak of hepatitis B virus (HBV) infections among injection drug users (IDUs) resulting in several deaths. We conducted a case-control study of fulminant (case patients) and nonfdminant (control patients

Seroprevalence of hepatitis C virus and
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000
✍ Fan-Chen Tseng; Thomas R. O'Brien; Mingdong Zhang; Alex H. Kral; Betty A. Ortiz- πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 196 KB πŸ‘ 2 views

Previous studies suggest that most injection drug users (IDUs) become infected with hepatitis C virus (HCV) and hepatitis B virus (HBV) soon after initiating drug use. The Urban Health Study (UHS) recruited serial cross-sections of IDUs in the San Francisco Bay area from 1986 to 2005. In the current